Nonlinear nightmare [General Sta­tis­tics]

posted by Helmut Homepage – Vienna, Austria, 2013-11-26 15:32 (4222 d 11:23 ago) – Posting: # 11972
Views: 15,139

Hi John,

❝ Have you goofed around with DDI before (drug interaction->inhibition)?


Yes, but always in steady state and not with CBZ.

❝ You can't run carbamazepine single dose BE due to autoinduction.


No? Single dose studies are recommended in all of FDA’s carbamazepine-guidances. I don’t think that full autoinduction is seen in the first dose. It will take the enzymes a while to tune up. That’s why I started to play around with time-dependent increase of clearance.

Regulators differ in their opinions whether CBZ is an NTID. Even if the conventional 80–125% are applicable to Cmax and AUC, pAUC would be a sensitive PK metric being able to discriminate between formulations with different absorption rates.

❝ We ran the BE program before and went with multiple-dose studies with no washout period like 8 yrs ago. I hope no one did...


Oh boy…

❝ I don't have Laszlo's paper so I don't know the details.


You’ve got mail. ;-)

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,674 registered users;
26 visitors (0 registered, 26 guests [including 9 identified bots]).
Forum time: 03:55 CEST (Europe/Vienna)

Philosophy, like medicine, has plenty of drugs, few good remedies,
and hardly any specific cures.    Sebastien-Roch Nicolas de Chamfort

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5